Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
EMERYVILLE, Calif., Sept. 8, 2020 /PRNewswire/ -- Amyris, Inc.. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo, President and Chief Executive Officer, will present during the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on Monday, September 14, 2020. The company will also be participating in virtual one-on-one meetings during the conference.
Amyris will provide an update on the progress and performance of its business during the presentation, which is scheduled for Monday, September 14, at 10:00 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company's website at http://investors.amyris.com. Due to the format of the virtual conference, no audience question and answer session will be available.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content to download multimedia:http://www.prnewswire.com/news-releases/amyris-to-present-at-hc-wainwright-22nd-annual-global-investment-conference-on-september-14-2020-301125140.html
SOURCE Amyris, Inc.
Company Codes: NASDAQ-NMS:AMRS